Search
Search
About
Log in
Join
Experiences with
Fedratinib
Posts
Communities
31 public posts
Filter results
Update on BMB
We’re also going to reduce my hydroxyurea from 1000 mg a day to 500 mg a day and continue taking my
Fedratinib
. My platelets have consistently been in the 700’s to 800’s, and my hemoglobin has been in the 10’s this year, so the medication is working. So that’s about it for now.
We’re also going to reduce my hydroxyurea from 1000 mg a day to 500 mg a day and continue taking my
Fedratinib
. My platelets have consistently been in the 700’s to 800’s, and my hemoglobin has been in the 10’s this year, so the medication is working. So that’s about it for now.
Cja1956
in
MPN Voice
3 years ago
Antibody test
I’m post ET MF and take hydroxyurea,
fedratinib
, and baby aspirin. I would appreciate any feedback.
I’m post ET MF and take hydroxyurea,
fedratinib
, and baby aspirin. I would appreciate any feedback.
Cja1956
in
MPN Voice
3 years ago
Loss of smell
I am post ET MF and take hydroxy,
fedratinib
, and baby aspirin. Has anyone else experienced this?
I am post ET MF and take hydroxy,
fedratinib
, and baby aspirin. Has anyone else experienced this?
Cja1956
in
MPN Voice
4 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Ongoing Research Poised to Add Options for Myelofibrosis Treatment
It talks a little about some newer developments also, other than 'Inrebic' (
Fedratinib
)...
It talks a little about some newer developments also, other than 'Inrebic' (
Fedratinib
)...
socrates_8
in
MPN Voice
5 years ago
New treatment options
https://www.targetedonc.com/news/expert-highlights-benefits-of-
fedratinib
-in-subgroup-of-patients-with-myelofibrosis Mesa: It’s an exciting time in MPNs without a doubt. I would break it down into 2 advances. The first is in patients with ET and PV.
https://www.targetedonc.com/news/expert-highlights-benefits-of-
fedratinib
-in-subgroup-of-patients-with-myelofibrosis Mesa: It’s an exciting time in MPNs without a doubt. I would break it down into 2 advances. The first is in patients with ET and PV.
Paul123456
in
MPN Voice
5 years ago
Hens teeth, aggressive sarcomatoid sccs and ruxolitinib
I see that
Fedratinib
has been approved : anyone here had any experience of it? Its supposed to be less immunosuppressive than ruxolitinib - or is that one of the others?
I see that
Fedratinib
has been approved : anyone here had any experience of it? Its supposed to be less immunosuppressive than ruxolitinib - or is that one of the others?
Rachelthepotter
in
MPN Voice
5 years ago
Fedratinib by Celgene, offered on Expanded Access Program for Myelofibrosis patients (in the U.S.)
Thought you might find this interesting - https://www.pvreporter.com/breaking-news-on-celgenes-
fedratinib
-for-myelofibrosis-patients/ Best, David - PV Reporter
Thought you might find this interesting - https://www.pvreporter.com/breaking-news-on-celgenes-
fedratinib
-for-myelofibrosis-patients/ Best, David - PV Reporter
PVReporter
in
MPN Voice
6 years ago
Fedratinib
Fedratinib
was successful trialed as a JAK2 inhibitor and possibly could have been of great benefit to patients who didn’t respond to Ruxo or for whom Ruxo stopped working. However trial was suspended due to health scare re side effects.
Fedratinib
was successful trialed as a JAK2 inhibitor and possibly could have been of great benefit to patients who didn’t respond to Ruxo or for whom Ruxo stopped working. However trial was suspended due to health scare re side effects.
Paul123456
in
MPN Voice
6 years ago
Ruxolitinib at last
At long last and unexpectedly I have been approved to commence Ruxolitinib/Jakavi I have PV and was previously on a
Fedratinib
trial.
At long last and unexpectedly I have been approved to commence Ruxolitinib/Jakavi I have PV and was previously on a
Fedratinib
trial.
hackett
in
MPN Voice
9 years ago
Does anyone else have bleeding with anagrelide?
Late last year i came off the
Fedratinib
trial and was placed back on Anagrelide. My current dose of 4 mg per day (previously it was 2mg /day) holds the platelet count quite well around the 400 mark , but I now very regularly suffer heavy nose and prostate bleeds.
Late last year i came off the
Fedratinib
trial and was placed back on Anagrelide. My current dose of 4 mg per day (previously it was 2mg /day) holds the platelet count quite well around the 400 mark , but I now very regularly suffer heavy nose and prostate bleeds.
hackett
in
MPN Voice
10 years ago
Sanofi discontinues clinical development of investigational JAK2 agent Fedratinib (SAR302503)
for the investigational JAK2 inhibitor
fedratinib
(SAR302503).
for the investigational JAK2 inhibitor
fedratinib
(SAR302503).
Mazcd
MPNVoice
in
MPN Voice
11 years ago
1
2
Filter results
Clear filters
Posted in
All communities
MPN Voice
31 results
Sort by
Most Relevant
Newest